To order this detailed 400+ page report, please visit this – https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html
Key Inclusions
An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and under development), affiliated approach, type of compatible pharmacological molecule(s) crossing the BBB (small molecule and biologic), target receptor(s), target disease indication(s), patent availability, and licensing activity. In addition, it presents a detailed assessment of BBB technology developers and analyses based on parameters, such as year of establishment, company size, and location of headquarters.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Payment Model Adopted
- Upfront payments
- Milestone payments
Type of Molecule
Small Molecules
Biologics
Target Disease Indication
- Brain Metastases in Breast Cancer
- Glioblastoma Multiforme
- Hunter Syndrome
- Hurler Syndrome
Leading Technology Platforms
- G®-Technology
- J-Brain Cargo® Technology
- LRP-1 Technology
- Trojan Horse Technology
Leading Drug Developers
- 2-BBB
- Angiochem
- ArmaGen
- JCR Pharmaceuticals
Key Geographical Regions
North America
Europe
Asia-Pacific
To request sample pages, please visit this – https://www.rootsanalysis.com/reports/310/request-sample.html
Key Questions Answered
- Who are the leading developers of BBB penetrating drugs and technologies?
- What are the key BBB penetrating technologies (available / under development) for delivery of CNS drugs?
- What are the key challenges faced by stakeholders engaged in this domain?
- Which partnership models are commonly adopted by stakeholders in this industry?
- Who are the most likely partners for BBB penetrating technology providers?
- What different strategies are used by BBB drug developers?
- What is the trend of capital investments in BBB related R&D?
- How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
- Novel Coronavirus (Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
- DNA-Encoded Libraries: Platforms and Services Market
- Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
